Taken together, SC ameliorates steatosis, inflammation, and fibrosis in NASH mice by activating hepatic and intestinal FXR signaling so as to suppress the levels of bile acid in NASH mouse liver and intestine. The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatohepatitis.